Board of Directors

Gordon Buchan has held a variety of senior business development and legal positions with several technology companies and law firms over a 25 year career. Educated as an electrical engineer and a lawyer (University of Western Ontario, 1971 and 1978 respectively), he initially specialized in Intellectual Property with an international boutique law firm in Ottawa. Most recently he retired as VP Business Development and Senior Legal Advisor from JDS Uniphase after 7 years with the company, where he had extensive experience in business development, intellectual property management, mergers and acquisitions, and was responsible for the management of the Commercial Legal Group and Intellectual Property Group.

Robert Cervelli, B.Sc, M.Sc., holds a Master’s Degree in Botany from the University of Wisconsin. Robert is the founder of Origin BioMed Inc. and has worked diligently to secure key international scientific, technical, business and investment relationships to support the company’s product development efforts and future prospects for growth. As a seasoned business executive with a number of biotechnology companies, he has also consulted for the public and private sector on technology patenting, commercialization and licensing.

Aki Georgacacos, CA, CFA, CF, has over 10 years of venture capital and corporate finance experience, most recently as Managing Director of FCC Ventures. At FCC Ventures, Aki led the majority of the fund's investments with a focus on industrial life sciences companies where he played an active role in the strategic growth of all portfolio companies. Before he became a venture capitalist, Aki was a Vice-President at Deloitte Corporate Finance in Calgary. He advised Canadian companies on public and private placements, mergers and acquisitions, divestitures, and strategies for maximization of shareholder value. At Deloitte, Aki led several assignments in the biotechnology, agri-food, distribution, health care, manufacturing, and oil and gas sectors. Previous investments include Agribiotics (Acquired by Merck), Bioniche Life Sciences (TSX: BNC). Brookside Foods, Ensyn, Kinnikinick and Sembiosys (TSX: SBS). Aki is a Chartered Accountant, CFA charterholder and holds a Bachelor of Commerce degree from the University of Saskatchewan.

Ed Mercadante, R.Ph. – Ed Mercadante has over 25 years of experience in the prescription health care, chain pharmacy and retail nutrition industries. Mr. Mercadante is Managing Member, President and Founder of Dante Capital Management LLC which operates healthcare, nutriceutical, and industry consulting businesses.  Currently, Mr. Mercadante is also still serving as Chairman, President and CEO of Familymeds Group, Inc, (“FMG”) a specialty pharmacy retail chain and medical specialty product provider. Mr. Mercadante received his B.S. degree in Pharmacy from the Philadelphia College of Pharmacy and is a registered pharmacist in numerous U.S. states.

Mr. Ronald Mitton, B.A., LL.B., received his law degree in 1972 from Dalhousie Law School. He practiced law with Macleod Dixon in Calgary, Alberta, before returning to Halifax to establish his own firm - Franklin Mitton Fountain & Thompson where he was senior partner between 1976 and 2007. On January 1, 2008, Mr. Mitton was appointed Senior Advisor-External to Dalhousie University, Halifax, Nova Scotia, with specific responsibility for the corporate and foundation sectors and their relationships with the University. Mr. Mitton has served on various Boards in the arts and cultural sector, and is the past Chairman of The Foundation of Heritage and the Arts which assisted the leading cultural organizations in Nova Scotia by providing expertise in board governance and strategic planning.

Mr. Barry Turner retired from Warner-Lambert at the time when they were acquired by Pfizer in 2000. He was Vice-President of Global Complementary Medicine for 3 years, directly responsible for global development of their natural medicines business segment and also involved in technology assessment and acquisition. Prior to that, he was President of Warner-Lambert Consumer HealthCare Canada for 4 years, with an earlier 6 years as Vice-President or Director of Marketing for Warner-Lambert Canada. Barry brings considerable experience in marketing and branding of consumer health products to Origin.

Mr. Peter MacNeil has been Investment Manager of NSBI Venture Capital since inception in 2001, Peter brings more than 28 years of expertise in financing business and, more specifically, 10 years of venture capital experience. He is also a member of Canada's Venture Capital & Private Equity Association and serves as a board member and observer on a number of investor companies. Born and raised in Nova Scotia, Peter holds a Commerce degree from Saint Mary's University (Halifax, Nova Scotia) and is a graduate of Venture Capital Institute of the National Venture Capital Association in the U.S. He also holds certificates in various industry training courses. In his spare time, Peter can be found on the green enjoying a round of golf and or at the rink coaching competitive curling.